EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Characterization of Prurigo Nodules in Adults With Moderate‐To‐Severe Atopic Dermatitis in Japan: A 2‐Year Observational Study

Yoko Kataoka iD, Takafumi Etoh iD, Hidehisa Saeki iD, Norito Katoh iD, Satoshi Teramukai iD, Yuki Tajima iD, Kwinten Bosman, Marius Ardeleanu, Kazuhiko Arima iD

The Journal of Dermatology · 2026-08 · 53 (8) · 1099-1114

DOI: 10.1111/1346-8138.70345 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Dermatology, online erschienen am 02.07.2026. Verfasst von Yoko Kataoka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Osaka Habikino Medical Center, Osaka, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Prurigo. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi K.K., Sanofi, Regeneron.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical phenotypes of atopic dermatitis (AD) can vary, with some individuals displaying difficult‐to‐treat prurigo nodularis‐like lesions. We aimed to assess the real‐world disease burden and treatment course of Japanese adults with AD‐associated prurigo nodules (AD‐Pn) receiving conventional AD treatments. Of the 300 participants with moderate‐to‐severe AD registered in the observational ADDRESS‐J study between July 29, 2016 and July 4, 2017 (before the first biologic for AD was introduced), 285 had baseline and post‐baseline prurigo assessments and were included in this exploratory analysis (108 with AD‐Pn and 177 without Pn). Participants with AD‐Pn versus those without Pn included more males (73.1% vs. 53.1%), and had more mean ± standard deviation (SD) visits for AD treatment in the previous year (11.5 ± 16.1 vs. 8.7 ± 6.6 visits), a higher proportion with an Investigator's Global Assessment (IGA) 4 score (39.9% vs. 18.6%), a higher mean ± SD Eczema Area and Severity Index (EASI) score (28.4 ± 15.1 vs. 23.5 ± 15.5), and a higher mean ± SD Patient‐Oriented Eczema Measure (POEM) score (18.8 ± 6.2 vs. 15.6 ± 6.8). At baseline, 14.8% and 7.4% of participants with AD‐Pn had been treated with oral immunosuppressants and oral corticosteroids, respectively, compared with 8.5% and 2.3%, respectively, of those without Pn. Individuals with AD‐Pn previously received more intensive topical treatments. At 2 years, participants with AD‐Pn had more severe AD than those without Pn, as assessed by IGA 4 scores (9.1% vs. 0.9%), and higher mean ± SD EASI total scores (12.5 ± 10.7 vs. 7.0 ± 8.1). In summary, individuals with AD‐Pn were mostly males, whose AD was more severe and had improved less than those without Pn while receiving mostly conventional AD treatments over 2 years. AD‐Pn might be an indicator for targeted treatment to improve long‐term AD outcomes. Clinical Trial Registration: ADDRESS‐J (UMIN Clinical Trial Registration: UMIN000022623)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPrurigoHumansMaleJapanSeverity of Illness IndexFemaleAdultMiddle AgedAgedTreatment OutcomeImmunosuppressive Agents

Stichwörter der Autor:innen

Japanatopic dermatitisobservational studyprurigosymptom burden

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Osaka Habikino Medical Center, Osaka, Japan.
  • Atago Dermatology Clinic, Tokyo, Japan.
  • Department of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan.
  • Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • North Campus, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.

ORCID-Profile: Yoko Kataoka, Takafumi Etoh, Hidehisa Saeki, Norito Katoh, Satoshi Teramukai, Yuki Tajima, Kazuhiko Arima

Förderung

  • Sanofi K.K.
  • Sanofi
  • Regeneron
  • Regeneron Pharmaceuticals

Zitieren

APA

Kataoka, Y., Etoh, T., Saeki, H., Katoh, N., Teramukai, S., Tajima, Y., Bosman, K., Ardeleanu, M., & Arima, K. (2026). Characterization of Prurigo Nodules in Adults With Moderate‐To‐Severe Atopic Dermatitis in Japan: A 2‐Year Observational Study. The Journal of Dermatology, 53(8), 1099-1114. https://doi.org/10.1111/1346-8138.70345

Vancouver

Kataoka Y, Etoh T, Saeki H, Katoh N, Teramukai S, Tajima Y, et al. Characterization of Prurigo Nodules in Adults With Moderate‐To‐Severe Atopic Dermatitis in Japan: A 2‐Year Observational Study. The Journal of Dermatology. 2026;53(8):1099-1114. doi:10.1111/1346-8138.70345

BibTeX
@article{Kataoka2026,
  author = {Kataoka, Yoko and Etoh, Takafumi and Saeki, Hidehisa and Katoh, Norito and Teramukai, Satoshi and Tajima, Yuki and Bosman, Kwinten and Ardeleanu, Marius and Arima, Kazuhiko},
  title = {Characterization of Prurigo Nodules in Adults With Moderate‐To‐Severe Atopic Dermatitis in Japan: A 2‐Year Observational Study},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {8},
  pages = {1099--1114},
  doi = {10.1111/1346-8138.70345}
}
Kostenlos starten →